Strategies to achieve fairer prices for generic and biosimilar medicines

BMJ. 2020 Jan 13:368:l5444. doi: 10.1136/bmj.l5444.

¹ Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Healthcare Institute, Boston, USA Alessandra_Ferrario@hphci.harvard.edu.
² Organisation for Economic Co-operation and Development, Paris, France.
³ World Health Organization, Regional Office for Europe, Copenhagen, Denmark.
⁴ WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies, Pharmacoeconomics Department, Gesundheit Österreich GmbH (GÖG/Austrian Public Health Institute), Vienna, Austria.
⁵ Discipline of Pharmaceutical Sciences, School of Health Sciences, University of KwaZulu-Natal, Durban, South Africa.

No abstract available

MeSH terms